Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Piperidinecarboxylic acid, 3-hydroxy, (2S,3S)-(9CI), commonly known as pipecolic acid, is a chiral organic compound that belongs to the piperidinecarboxylic acid family. It is a natural amino acid derivative found in the body and possesses various biological functions, such as acting as a neurotransmitter and regulating the immune system. The (2S,3S) configuration denotes the specific stereochemistry of the compound, which is crucial for its biological activity and applications.

176019-05-9 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 176019-05-9 Structure
  • Basic information

    1. Product Name: 2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI)
    2. Synonyms: 2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI);2-Piperidinecarboxylicacid, 3-hydroxy-, (2S,3S)-;(2S,3S)-3-HYDROXYPIPERIDINE-2-CARBOXYLIC ACID
    3. CAS NO:176019-05-9
    4. Molecular Formula: C6H11NO3
    5. Molecular Weight: 145.16
    6. EINECS: N/A
    7. Product Categories: CARBOXYLICACID
    8. Mol File: 176019-05-9.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: N/A
    3. Flash Point: N/A
    4. Appearance: /
    5. Density: N/A
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI)(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI)(176019-05-9)
    11. EPA Substance Registry System: 2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI)(176019-05-9)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 176019-05-9(Hazardous Substances Data)

176019-05-9 Usage

Uses

Used in Pharmaceutical Industry:
2-Piperidinecarboxylic acid, 3-hydroxy, (2S,3S)-(9CI) is used as a building block in the synthesis of pharmaceuticals for its unique biological properties and stereochemistry. Its presence as a natural amino acid derivative allows it to be incorporated into various drug molecules, enhancing their efficacy and selectivity.
Used in Agrochemical Industry:
In the agrochemical industry, 2-Piperidinecarboxylic acid, 3-hydroxy, (2S,3S)-(9CI) serves as a key intermediate in the synthesis of agrochemicals, such as pesticides and herbicides. Its chiral nature and biological activity make it a valuable component in the development of novel and effective agrochemical products.
Used in Neurotransmission Research:
2-Piperidinecarboxylic acid, 3-hydroxy, (2S,3S)-(9CI) is utilized in neurotransmission research due to its role as a neurotransmitter. Its unique stereochemistry and biological activity make it an important compound for studying the mechanisms of neurotransmission and developing potential therapeutic agents for neurological disorders.
Used in Immune System Regulation:
2-Piperidinecarboxylicacid,3-hydroxy-,(2S,3S)-(9CI) is also used in the study and regulation of the immune system, given its role in modulating immune responses. The specific stereochemistry of the (2S,3S) configuration allows researchers to investigate its interactions with immune cells and develop potential immunomodulatory agents based on its structure and function.

Check Digit Verification of cas no

The CAS Registry Mumber 176019-05-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,6,0,1 and 9 respectively; the second part has 2 digits, 0 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 176019-05:
(8*1)+(7*7)+(6*6)+(5*0)+(4*1)+(3*9)+(2*0)+(1*5)=129
129 % 10 = 9
So 176019-05-9 is a valid CAS Registry Number.

176019-05-9SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 20, 2017

Revision Date: Aug 20, 2017

1.Identification

1.1 GHS Product identifier

Product name (2S,3S)-3-hydroxypiperidine-2-carboxylic acid

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:176019-05-9 SDS

176019-05-9Downstream Products

176019-05-9Relevant articles and documents

Modular Chemoenzymatic Synthesis of GE81112 B1 and Related Analogues Enables Elucidation of Its Key Pharmacophores

Zwick, Christian R.,Sosa, Max B.,Renata, Hans

supporting information, p. 1673 - 1679 (2021/01/25)

The GE81112 complex has garnered much interest due to its broad antimicrobial properties and unique ability to inhibit bacterial translation initiation. Herein we report the use of a chemoenzymatic strategy to complete the first total synthesis of GE81112 B1. By pairing iron and α-ketoglutarate dependent hydroxylases found in GE81112 biosynthesis with traditional synthetic methodology, we were able to access the natural product in 11 steps (longest linear sequence). Following this strategy, 10 GE81112 B1 analogues were synthesized, allowing for identification of its key pharmacophores. A key feature of our medicinal chemistry effort is the incorporation of additional biocatalytic hydroxylations in modular analogue synthesis to rapidly enable exploration of relevant chemical space.

Studies on the selectivity of proline hydroxylases reveal new substrates including bicycles

Smart, Tristan J.,Hamed, Refaat B.,Claridge, Timothy D.W.,Schofield, Christopher J.

supporting information, (2019/11/26)

Studies on the substrate selectivity of recombinant ferrous-iron- and 2-oxoglutarate-dependent proline hydroxylases (PHs) reveal that they can catalyse the production of dihydroxylated 5-, 6-, and 7-membered ring products, and can accept bicyclic substrates. Ring-substituted substrate analogues (such hydroxylated and fluorinated prolines) are accepted in some cases. The results highlight the considerable, as yet largely untapped, potential for amino acid hydroxylases and other 2OG oxygenases in biocatalysis.

Furan-Derived Chiral Bicycloaziridino Lactone Synthon: Collective Syntheses of Oseltamivir Phosphate (Tamiflu), (S)-Pipecolic acid and its 3-Hydroxy Derivatives

Chavan, Subhash P.,Gonnade, Rajesh G.,Kadam, Appasaheb L.,Shinde, Shrikrishna S.

, (2020/02/05)

A unified synthetic strategy for oseltamivir phosphate (tamiflu), (S)-pipecolic acid, and its 3-hydroxy derivatives from furan derived common chiral bicycloaziridino lactone synthon is described here. Key features are the short (4-steps), enantiopure, and decagram-scale synthesis of common chiral synthon from furan and its first-ever application in the total synthesis of biologically active compounds by taking the advantages of high functionalization ability of chiral synthon.

Enantioselective syntheses of (R)-pipecolic acid, (2R,3R)-3-hydroxypipecolic acid, β-(+)-conhydrine and (-)-swainsonine using an aziridine derived common chiral synthon

Chavan, Subhash P.,Khairnar, Lalit B.,Pawar, Kailash P.,Chavan, Prakash N.,Kawale, Sanket A.

, p. 50580 - 50590 (2015/06/25)

Concise total syntheses of (R)-pipecolic acid, (R)-ethyl-6-oxopipecolate, (2R,3R)-3-hydroxypipecolic acid and formal syntheses of β-(+)-conhydrine, (-)-lentiginosine, (-)-swainsonine and 1,2-di-epi-swainsonine have been accomplished starting from a common chiral synthon. The present strategy employs regioselective aziridine ring opening, Wittig olefination and RCM as the key chemical transformations.

METHOD FOR PRODUCING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID DERIVATIVE, AND METHOD FOR PURIFYING cis-5-HYDROXY-2-PIPERIDINECARBOXYLIC ACID

-

Paragraph 0164; 0165, (2015/07/15)

The present invention aims to provide a method for purifying cis-5-hydroxy-2-piperidinecarboxylic acid with high purity, and a method for producing its derivative. The present invention provides a method for producing a cis-5-hydroxy-2-piperidinecarboxylic acid derivative, which method comprises a step of converting cis-5-hydroxy-2-piperidinecarboxylic acid into a compound(s) of Formula (1) and/or Formula (2) (wherein R1 represents a protective group for an amino group, and R2 represents a C1-C6 alkyl group), and a method for purifying cis-5-hydroxy-2-piperidinecarboxylic acid.

Organocatalyzed synthesis of (-)-4-epi-fagomine and the corresponding pipecolic acids

Marjanovic, Jasna,Ferjancic, Zorana,Saicic, Radomir N.

, p. 6784 - 6789 (2015/08/24)

The enantioselective synthesis of 4-epi-fagomine was accomplished starting from dioxanone and Cbz-protected benyzlamine, in 4 steps, with 18% overall yield. The key feature of this synthetic approach is the tactical combination of reactions: organocatalyz

Regio- and stereoselective oxygenation of proline derivatives by using microbial 2-oxoglutarate-dependent dioxygenases

Hara, Ryotaro,Uchiumi, Naoko,Okamoto, Naoko,Kino, Kuniki

, p. 1384 - 1388 (2015/07/20)

We evaluated the substrate specificities of four proline cis-selective hydroxylases toward the efficient synthesis of proline derivatives. In an initial evaluation, 15 proline-related compounds were investigated as substrates. In addition to L-proline and L-pipecolinic acid, we found that 3,4-dehydro-L-proline, L-azetidine-2-carboxylic acid, cis-3-hydroxy-L-proline, and L-thioproline were also oxygenated. Subsequently, the product structures were determined, revealing cis-3,4-epoxy-L-proline, cis-3-hydroxy-L-azetidine-2-carboxylic acid, and 2,3-cis-3,4-cis-3,4-dihydroxy-L-proline.

A short synthesis of (2S,3S)-3-hydroxypipecolic acid

Chavan, Subhash P.,Harale, Kishor R.,Pawar, Kailash P.

supporting information, p. 4851 - 4853 (2013/09/02)

A convenient synthesis of (2S,3S)-3-hydroxypipecolic acid starting from cheap and abundant l-(+)-tartaric acid has been achieved. The strategy employs selective ester reduction and reductive lactamization as key steps.

Synthesis of (+)-L-733,060, (+)-CP-99,994 and (2S,3R)-3-hydroxypipecolic acid: Application of an organocatalytic direct vinylogous aldol reaction

Pansare, Sunil V.,Paul, Eldho K.

experimental part, p. 2119 - 2125 (2012/04/17)

The γ-butenolide obtained from an organocatalyzed, direct vinylogous aldol reaction of γ-crotonolactone and benzaldehyde serves as the key starting material in the expedient synthesis of a 3-hydroxy-2-phenyl piperidine intermediate which is converted to the target 2,3-disubstituted piperidines.

A simple procedure for selective hydroxylation of L -proline and l -pipecolic acid with recombinantly expressed proline hydroxylases

Klein, Christian,Huettel, Wolfgang

experimental part, p. 1375 - 1383 (2011/06/26)

Due to their diverse regio- and stereoselectivities, proline hydroxylases provide a straightforward access to hydroxprolines and other hydroxylated cylic amino acids, valuable chiral building blocks for chemical synthesis, which are often not available at reasonable expense by classical chemical synthesis. As yet, the application of proline hydroxylases is limited to a sophisticated industrial process for the production of two hydroxyproline isomers. This is mainly due to difficulties in their heterologues expression, their limited in vitro stability and complex product purification procedures. Here we describe a facile method for the production of cis-3-, cis-4- and trans-4-proline hydroxylase, and their application for the regio- and stereoselective hydroxylation of L-proline and its six-membered ring homologue l-pipecolic acid. Since in vitro catalysis with these enzymes is not very efficient and conversions are restricted to the milligram scale, an in vivo procedure was established, which allowed a quantitative conversion of 6 mM l-proline in shake flask cultures. After facile product purification via ion exchange chromatography, hydroxyprolines were isolated in yields of 35-61% (175-305 mg per flask). L-Pipecolic acid was converted with the isolated enzymes to prove the selectivities of the reactions. In transformations with optimized iron(II) concentration, conversions of 17-68% to hydroxylated products were achieved. The regio- and stereochemistry of the products was determined by NMR techniques. To demonstrate the applicability of the preparative in vivo approach for non-physiological substrates, L-pipecolic acid was converted with an E. coli strain producing trans-4-proline hydroxylase to trans-5-hydroxy-L-pipecolic acid in 61% yield. Thus, a synthetically valuable group of biocatalysts was made readily accessible for application in the laboratory without a need for special equipment or considerable development effort.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 176019-05-9